193 related articles for article (PubMed ID: 17204321)
1. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone.
Ito T; Fraser IP; Yeo Y; Highley CB; Bellas E; Kohane DS
Biomaterials; 2007 Apr; 28(10):1778-86. PubMed ID: 17204321
[TBL] [Abstract][Full Text] [Related]
2. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives.
Ito T; Yeo Y; Highley CB; Bellas E; Benitez CA; Kohane DS
Biomaterials; 2007 Feb; 28(6):975-83. PubMed ID: 17109954
[TBL] [Abstract][Full Text] [Related]
3. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide.
Yeo Y; Adil M; Bellas E; Astashkina A; Chaudhary N; Kohane DS
J Control Release; 2007 Jul; 120(3):178-85. PubMed ID: 17582645
[TBL] [Abstract][Full Text] [Related]
4. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
Lee F; Chung JE; Kurisawa M
J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
[TBL] [Abstract][Full Text] [Related]
5. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model.
Yeo Y; Highley CB; Bellas E; Ito T; Marini R; Langer R; Kohane DS
Biomaterials; 2006 Sep; 27(27):4698-705. PubMed ID: 16750564
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid.
Jia X; Colombo G; Padera R; Langer R; Kohane DS
Biomaterials; 2004 Aug; 25(19):4797-804. PubMed ID: 15120526
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention.
Li L; Wang N; Jin X; Deng R; Nie S; Sun L; Wu Q; Wei Y; Gong C
Biomaterials; 2014 Apr; 35(12):3903-17. PubMed ID: 24507411
[TBL] [Abstract][Full Text] [Related]
8. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
[TBL] [Abstract][Full Text] [Related]
9. Combination material delivery of dexamethasone and growth factor in hydrogel blended with hyaluronic acid constructs for neocartilage formation.
Na K; Kim S; Woo DG; Sun BK; Yang HN; Chung HM; Park KH
J Biomed Mater Res A; 2007 Dec; 83(3):779-86. PubMed ID: 17559114
[TBL] [Abstract][Full Text] [Related]
10. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.
Kim J; Kim IS; Cho TH; Lee KB; Hwang SJ; Tae G; Noh I; Lee SH; Park Y; Sun K
Biomaterials; 2007 Apr; 28(10):1830-7. PubMed ID: 17208295
[TBL] [Abstract][Full Text] [Related]
11. Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization.
Rangasami VK; Samanta S; Parihar VS; Asawa K; Zhu K; Varghese OP; Teramura Y; Nilsson B; Hilborn J; Harris RA; Oommen OP
Carbohydr Polym; 2021 Feb; 254():117291. PubMed ID: 33357860
[TBL] [Abstract][Full Text] [Related]
12. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
Varghese OP; Sun W; Hilborn J; Ossipov DA
J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
[TBL] [Abstract][Full Text] [Related]
13. A novel controlled local drug delivery system for inner ear disease.
Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
[TBL] [Abstract][Full Text] [Related]
14. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.
Hirakura T; Yasugi K; Nemoto T; Sato M; Shimoboji T; Aso Y; Morimoto N; Akiyoshi K
J Control Release; 2010 Mar; 142(3):483-9. PubMed ID: 19951730
[TBL] [Abstract][Full Text] [Related]
15. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers.
Lai JY; Ma DH; Cheng HY; Sun CC; Huang SJ; Li YT; Hsiue GH
J Biomater Sci Polym Ed; 2010; 21(3):359-76. PubMed ID: 20178691
[TBL] [Abstract][Full Text] [Related]
16. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration.
Yeom J; Bhang SH; Kim BS; Seo MS; Hwang EJ; Cho IH; Park JK; Hahn SK
Bioconjug Chem; 2010 Feb; 21(2):240-7. PubMed ID: 20078098
[TBL] [Abstract][Full Text] [Related]
17. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel.
Yu D; Sun C; Zheng Z; Wang X; Chen D; Wu H; Wang X; Shi F
Int J Pharm; 2016 Apr; 503(1-2):229-37. PubMed ID: 26972377
[TBL] [Abstract][Full Text] [Related]
18. Bioimaging of dexamethasone and TGF beta-1 and its biological activities of chondrogenic differentiation in hydrogel constructs.
Na K; Kim S; Sun BK; Woo DG; Yang HN; Chung HM; Park KH
J Biomed Mater Res A; 2008 Nov; 87(2):283-9. PubMed ID: 18181092
[TBL] [Abstract][Full Text] [Related]
19. Functionalization of hyaluronic acid with chemoselective groups via a disulfide-based protection strategy for in situ formation of mechanically stable hydrogels.
Ossipov DA; Piskounova S; Varghese OP; Hilborn J
Biomacromolecules; 2010 Sep; 11(9):2247-54. PubMed ID: 20704177
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel.
Li H; Liu Y; Shu XZ; Gray SD; Prestwich GD
Biomacromolecules; 2004; 5(3):895-902. PubMed ID: 15132679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
